Joshua R Colombo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Medullary thyroid cancer is uncommon and patients typically present with advanced disease. Treatment options for patients with progressive, metastatic medullary thyroid cancer had been limited until recently. Tyrosine kinase inhibitors have garnered increasing interest in this subset of patients. The US Food and Drug Administration recently approved(More)
  • 1